James R. Schmidt serves as Chief Financial Officer of Alume Biosciences. He has over 30 years of executive financial experience in the biomedical and technology sectors. Since 2013, he has worked with companies as consulting CFO ranging from private, early formation to publicly traded. He served as Vice President of Finance and Administration at Receptos, Inc. from 2009 to 2013. From 2007 to 2009 he served as Senior Director of Finance and Operations for Apoptos, Inc. which was acquired by Receptos, Inc. in May 2009. He was formerly Senior Director of Finance and Operations at Conforma Therapeutics from 2001 until its acquisition by Biogen Idec in 2006, where he assisted in the transition and integration of the companies. Prior to that, from 1986 to 2001 Mr. Schmidt served in various financial and operational roles. He started his career with Coopers Lybrand and received his B.S. in Accounting and Corporation Finance from Drake University in Des Moines, Iowa.